Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

ECDC advocates for execution of respiratory syncytial virus (RSV) immunization programs including maternal vaccines to protect infants from severe hospitalization.

The Iowa Department of Health and Human Services (HHS) announces today the first influenza-related death of the 2025-26 ...

Welcome to Sideline Spotlight! It's week 3 of high school football playoffs in Tennessee and week 2 in Georgia.See the final ...

Iowa Health and Human Services officials announced Friday that it has recorded the first flu-related death of the season.

China's National Disease Control and Prevention Administration warned on Monday of a general uptick in acute respiratory ...

The United States may be headed for a rough flu season, with a virus that causes more severe symptoms than the one last year ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing ...

Tablet blue light may not disrupt sleep or melatonin in children aged 15–24 months, challenging widespread assumptions about ...

Pfizer’s respiratory syncytial virus vaccine was more than 90% effective among older adults during the first season it was available, including among those with underlying conditions or severe disease ...